期刊文献+

前列腺癌nm23H1mRNA、TGF-β1mRNA表达及其与肿瘤转移、生存率的相关性研究 被引量:12

STUDY ON THE CORRELATIONSHIP BETWEEN THE EXPRESSION OF nm23H1mRNA, TGF-β1mRNA AND TUMOR METASTASES,SURVIVAL RATE WITH PROSTATE CANCER
下载PDF
导出
摘要 应用原位杂交法检测42例前列腺癌组织nm23H1mRNA、TGF-β1mRNA表达,并以CD31抗体为标记,经EnVision^(TM)免疫组织化学及Leica-Qwin计算机图像分析,用Weidner最高血管密度计数法,计数阳性MVD,研究前列腺癌组织nm23H1mRNA、TGF-β1mRNA和CD31的表达与前列腺癌中的新生血管的生成、肿瘤血道转移和调查患者术后的生存率关系。前列腺癌nm23H1mRNA阳性表达66.67%(28例),nm23H1mRNA阳性表达与前列腺癌骨转移、TNM分期、MVD呈负相关(P<0.05):TGF-β1mRNA阳性表达78.75%(33例),其与前列腺癌骨转移、TNM分期、MVD呈正相关(P<0.05),与癌周组织的nm23H1mRNA和TGF-β1mRNA阳性表达比较,具有显著性差异(P<0.01或P<0.05)。前列腺癌组织的MVD(78.51±10.29/mm^2)显著高于癌周组织(34.19±9.27/mm^2),两者比较具有显著性差异(P<0.05)。在根治术后5年内死亡的42.86%(18例)患者中MVD(92.41±15.42/ mm^2),高于5年内生存的患者(62.79±13.58/mm^2),两组间有显著性差异(P<0.05);在不同的肿瘤病理学分级中,nm23H1mRNA在前列腺癌未、低分化型中阳性表达率高,高、中分化型中阳性表达率低,两组间有显著性差异(P<0.05)。当nm23H1mRNA阳性表达率高时,肿瘤骨转移率低,生存率高,故认为nm23H1基因具有抑制前列腺癌发生和转移作用。当TGF-β1mRNA阳性表达率高时,肿瘤骨转移率高,生存率低。故认为TGF-β1基因具有促进前列腺癌发生和转移作用。前列腺癌组织中的MVD与肿瘤骨转移密切相关,前列腺癌组织MVD的显著增高,提示肿瘤组织有新血管的生成。TGF-β1促进了肿瘤诱导的血管新生,在前列腺癌的骨转移中起重要作用。 All the specimens were marked by CD31 antibody, the expression of nm23H1mRNA, TGF-β1mRNA was detected in 42 cases of prostate cancer in situ hybridization with EnVision^TM and Leica-Qwin computer image analysis system. The Weidner's highest vessel density counting method was used to analysis the microvessel density(MVD) of the specimens,and the patients'viability rate after operation was investigated. The correlation between the expression of nm23H1mRNA,TGF-β1mRNA,CD31 and neoangiogenesis, hyperplasia of microvessel, tumor metastases in prostate cancer was studied. The positive expression of nm23H1mRN in prostate cancer was 66.67% (28 cases). There was negative correlation between the positive expression of nm23H1mRNA and bone metastasizing,TNM staging,MVD in prostate cancer (P〈0.05). The positive expression of TGF-β1mRNA was 78.75%(33 cases), and was positive correlative to the bone metastasis, TNM stages, MVD in prostate cancer (P〈0.05). It is significantly different(P〈0.01 or P〈0.05) with that in adjacent nontumorous tissue. The MVD (78.51±0.29/mm^2) in prostate cancer was significantly (P〈0.05) higher than that in adjacent nontumorous tissue (34.19±9.27/mm^2). The MVD (92.41±15.42/mm^2) in those who died in five years (18 cases) was significantly higher(P〈0.05) than that(62.79±3.58/mm^2) in those who were still alive. In tumor pathology grading,different differentiation, the difference of nm23H1mRNA positive expression was statistically significant (P〈 0.05). Higher the nm23H1mRNA expressed,lower the bone metastasized,and higher the viability rate was. Therefore, the nm23H1 gene was thought to have the effect of suppressing prostate cancer occurring and bone metastasizing. Higher the TGF-β1mRNA expressed, higher the tumor bone metastasized, and lower the viability rate was. Therefore, the TGF-β1 gene was thought to have the promote genesis and metastasize of prostate cancer. There is close correlation between the CD31 expre
出处 《分子细胞生物学报》 CSCD 北大核心 2006年第6期544-552,共9页 Journal of Molecular Cell Biology
基金 浙江省自然科学基金资助项目(No:Y205519) 浙江省教育厅科研基金资助项目(No:20040540)。
关键词 nm23H1mRNA TGF-βmRNA MVD 肿瘤转移 前列腺癌 nm23H1mRNA. TGF-β1mRNA. MVD. Tumor metastases. Prostate cancer
  • 相关文献

参考文献11

  • 1Stravodimos, K., C. Constantinides, T. Manousakas, C.Pavlaki, D. Pantazopoulos, A. Giannopoulos, & C. Dimopoulos, 2000, Immunohistochemical expression of transforming growth factor beta 1 and nm-23H1 antioncogene in prostate cancer: divergent correlation with clinicopathological parameters. A nticancer Res., 20 (5) :3823-3828. 被引量:1
  • 2Roberts,A & Spom, M., 1996,Transforming growth factor β in molecular and cellular biology of wound repair,PAF Clank, Med. New York, Plenum Press., 43 (15) :275-308. 被引量:1
  • 3Jacquemier, J., M. P. Mathoulin-Portier, R. Valtola, E.Charafe -Jauffret, J. Geneix, G.Houvenaeghel, B. Puig,V.J. Bardou,J. Hassoun,P. Viens & D. Birnbaum,2000,Prognosis of breast carcinoma lymphangiogenesis evaluated by immunohistochemicnal investigation of vascular-endothelial-growth-factor recptor 3. Int. J. Cancer, 89(1): 69-73. 被引量:1
  • 4Akagi, K., Y. Ikeda, M. Miyazaki,T. Abe, J. Kinoshita,Y. Maehara & K. Sugimachi, 2000, Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br. J. Cancer, 83: 887-891. 被引量:1
  • 5Weidner, N., J. P. Semple,W. R. Welch & J. Folkman,1991 ,Tumor angiogenesis and metastasis : correlation in invasive breast carcinoma. N. Engl. J. Med, 324: 1-8. 被引量:1
  • 6Kaplan, E. L & P. Meier., 1958, Parametric estimation from incomplete observation. J. Am. Star. Assoc. 53: 457 -481. 被引量:1
  • 7Steeg,P. S.,G. Bevilacqua & L. Kopper, 1988,Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Canaer.Inst, 80(3): 200-204. 被引量:1
  • 8Russell, R. L., A. N. Pedersen, J. Kantor, K. Geisinger,R. Long, N. Zbieranski, A. Townsend, B. Shelton, N.Brunne. & T.E. Kute, 1998, Relationship of nm23 to proteolytic factor,proliferation and motility in breast cancer tissues and cell lines. Br. J. Cancer, 78(6) : 710-717. 被引量:1
  • 9Shariat,S. F,J. H. Kim,B. Andrews, M. W. Kattan, T. M. Wheeler,I. Y. Kim,S. P. Lemer & S. P. L.Slawin, 2001, Preoperative plasma levels of transforming growth factor beta (1) strongly predict clinical outcome in patients with bladder carcinoma. Cancer, 92(12):2985-2992. 被引量:1
  • 10Cardillo, M. R., E. Petrangeli, L. Perracchio, L. Salvatori, L. Ravenna & F. Di Silverio, 2000, Transforming growth factor-beta expression in prostate neoplasia. J.Anal. Quant. Cytol. Histol., 22(1):1-10. 被引量:1

同被引文献107

引证文献12

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部